Differentiating Viral Myositis from Autoimmune Myositis in Teenagers

Clinical Presentation Differences

The American College of Physicians suggests that autoimmune myositis develops subacutely over weeks to months with proximal muscle weakness, persistently elevated muscle enzymes, and positive myositis-specific autoantibodies 1, 2
Autoimmune myositis is characterized by true proximal muscle weakness, difficulty standing from a seated position, climbing stairs, and lifting arms overhead, with symmetric involvement of proximal upper and lower extremities 1, 2, 3

The Mayo Clinic recommends that persistently elevated creatine kinase (CK) levels, often markedly so, are characteristic of autoimmune myositis, while viral myositis typically has normal to mildly elevated CK levels 1, 2
Myositis-specific autoantibodies, such as anti-Jo-1, anti-Mi-2, anti-MDA5, anti-TIF1-gamma, and anti-NXP2, are present in autoimmune myositis and define clinical phenotypes, according to the American College of Rheumatology 1, 2, 3

Electromyography (EMG) shows polyphasic motor unit action potentials of short duration and low amplitude, increased insertional activity, fibrillation potentials, and sharp waves in autoimmune myositis, as stated by the American Association of Neuromuscular and Electrodiagnostic Medicine 1
MRI imaging with T2-weighted sequences and fat suppression shows diffuse muscle edema in proximal muscle groups in autoimmune myositis, useful for identifying biopsy sites, according to the Radiological Society of North America 1, 2

The temporal course of symptoms is a practical differentiator, with viral myositis symptoms peaking within 24-48 hours and resolving within 3-7 days, while autoimmune myositis progressively worsens over weeks to months without immunosuppressive treatment, as suggested by the European League Against Rheumatism 1, 2

The American College of Physicians recommends assessing symptom onset and duration, distinguishing pain from weakness, checking CK and repeating in 3-5 days, ordering myositis-specific autoantibodies, examining for dermatomyositis rash, and proceeding to EMG and MRI imaging if diagnosis remains unclear after 7 days 1, 2, 3